Overview
What is Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict)?
Wisconsin Institute for Immune and Cell Therapy Inc., often referred to as Wiict, is a nonprofit organization situated in Madison, Wisconsin. Primarily focused on medical research, Wiict collaborates with a hospital to conduct ongoing studies in this field. In 2022, Wiict specialized in designing and producing multiple mRNAs, meticulously analyzing each one for various properties and effectiveness in manufacturing cell therapies for patients with primary immune deficiency (PID) diseases caused by gene mutations. Wiict provided optimized versions of these mRNAs to its clinical collaborators at the National Institutes of Health Clinical Center in Bethesda, Maryland, for use in clinical research. The ultimate goal is to generate data supporting the filing and implementation of an Investigational New Drug (IND) application for a phase I or phase I/II human clinical trial for one of these PID diseases. With a workforce of four individuals, Wiict is dedicated to advancing medical research in the field of cell therapy.
Official website here: www.none
Is Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict) legitimate?
Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict) is a legitimate nonprofit organization registered as a 501(c)(3) entity. Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict) submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $197,100
For more financial information, click here
What is the mission statement of Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict)?
The Wisconsin Institute for Immune and Cell Therapy Inc., often referred to as Wiict, is primarily dedicated to the continuous active conduct of medical research in collaboration with a hospital. This mission is aimed at designing and analyzing various messenger RNAs (mRNAs) in 2022. The analyzed mRNAs are optimized and provided to clinical collaborators for use in clinical research, not only in human cells but also in animal cells and animal models. The goal is to select the most optimal mRNA constructs and generate clinical data to support the filing and implementation of an Investigational New Drug (IND) application for a phase I or phase I/II human clinical trial for primary immune deficiency (PID) diseases caused by gene mutations.
Official website here: www.none
Who is the CEO of Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict)?
Gary Dahl is the President And Director of Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict).
Official website here: www.none
What is the revenue of Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict)?
Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict)'s revenue in 2022 was $500,000.
Official website here: www.none
Who are the executives of Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict) and what are their salaries?
The average compensation at Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict) during 2022 was $49,275. There are 4 employees and 3 volunteers at Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict).
Here are 3 key members and their salaries:
- Gary A Dahl (President And Director)
- Jerome J Jendrisak (Vp, Secr./Treas., Director)
- Kieran Coe (Director)
Official website here: www.none
Learn more at the official website: www.none
Mission Statement of Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict)
Wisconsin Institute for Immune and Cell Therapy Inc., or Wiict, is dedicated to advancing medical research in conjunction with a hospital. The organization's primary mission is to continuously engage in active medical research, focusing on designing, analyzing, and evaluating multiple mRNAs. The aim is to optimize these mRNAs for potential use in manufacturing cell therapies for treating primary immune deficiency (PID) diseases caused by gene mutations in human patients.
Wiict's research involves examining various aspects of the mRNAs, including yield, purity, size, nucleic acid sequence, cap structure, tail length, concentration, potency, and other chemical, biochemical, and physical properties. The goal is to create the most effective versions of these mRNAs for use in clinical research, both in human and animal cells and in animal models. This process helps in selecting the optimal mRNA constructs and generating clinical data to support the filing and implementation of an Investigational New Drug (IND) application for a phase I or phase I/II human clinical trial for one of these PID diseases. By conducting such research, Wiict aims to contribute to the development of innovative cell therapies for treating these debilitating immune disorders.
Impact
This information is meant to be a general summary of Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict). Please take the time to review official sources before making any decisions based upon the content provided here.
Wednesday, July 24, 2024
Wisconsin Institute For Immune And Cell Therapy Inc (Wiict) impacts the medical research field by actively conducting research in immune and cell therapy in collaboration with hospitals. Their work aims to advance the understanding and treatment of various medical conditions through innovative research initiatives. This organization plays a crucial role in advancing medical knowledge and improving patient care by focusing on cutting-edge therapies and treatments. Their efforts contribute to the ongoing development of medical science and have the potential to make a significant impact on the healthcare landscape.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
2021
Phone
(608) 729-1450
Principal Officer
Gary Dahl
Main Address
726 POST ROAD, MADISON, WI, 537134620
Website
www.none
NTEE Category
Code: H99 - Medical research
If you are a representative of Wisconsin Institute For Immune And Cell Therapy Inc (Aka Wiict) and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.